Goal and Learning Outcomes

Upon completion of this activity, participants will be able to:

  • Evaluate novel and emerging approaches to prenatal and newborn screening for SMA
  • Describe clinical trial evidence that demonstrates the benefits of early treatment implementation in patients with SMA
  • Analyze appropriate treatments for pediatric and adult patients with SMA based on currently available efficacy and safety data of current and emerging therapies
  • Integrate team-based strategies to improve transition of care in patients with SMA as age increases


W. David Arnold, MD

Associate Professor - Clinical
Division of Neuromuscular
Department of Neurology
The Ohio State University Wexner Medical Center
Columbus, OH

Nancy L. Kuntz, MD

Attending Physician
Division of Neurology
Mazza Foundation Neuromuscular Program Medical Director
Muscular Dystrophy Association Clinic Ann & Robert H. Lurie Children’s Hospital of Chicago
PPMD Duchenne Care Center and MDA Care Center Professor of Pediatrics and Neurology Northwestern University Feinberg School of Medicine
Chicago, IL

Emma Ciafaloni, MD

Robert C. and Rosalyne H. Griggs Professor in Experimental Therapeutics of Neurologic Disease
Professor of Neurology, Pediatrics and Obstetrics and Gynecology
Director Pediatric Neuromuscular Medicine
University of Rochester
Rochester, NY

Debra Guntrum, MS, FNP, ANCC

Nurse Practitioner
Neuromuscular Disease Center
University of Rochester Medical Center
Rochester, NY

Accreditation Information

This course is being provided by a Relias LLC strategic partner.  Consumption of this course will take place on the partners site and courses provided in this manner are not accredited by Relias LLC.